Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06065319 · ClinicalTrials.gov registry record
Wearables and Cardiac Rehabilitation
A clinical trial of Cardiac Rehabilitation, sponsored by Texas A&M University.
- Active
- Registry status
- 18
- Enrollment target
- 2
- Study locations
NCT06065319: Active study of Cardiac Rehabilitation, sponsored by Texas A&M University.
NCT06065319 is a study of Cardiac Rehabilitation that is active but no longer recruiting, run by Texas A&M University. The registered enrollment target is 18 participants, below the 164-participant average among 13 other Cardiac Rehabilitation trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06065319, a study of Cardiac Rehabilitation, is active but no longer recruiting, sponsored by Texas A&M University.
- ACTIVE NOT RECRUITING
- Registry status
- 18 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to collect wearable sensor data that the investigators hypothesize will be useful in future algorithm development for monitoring recovering of participants enrolled in cardiac rehabilitation programs. Participants will be provided one or more smartwatches and/or smart rings to wear during a 14 week study which includes 2 weeks of baseline data collection and a 12-week, 36-session cardiac rehabilitation program. They will capture a pre-assessment 6 minute walk tests and a post-assessment 6 minute walk test. They will otherwise conduct standard cardiac rehabilitation program procedures and our sensors will capture data and sleep information throughout the study period.
Primary Outcome
Improvement in the 6 minute walk test performance from pre assessment to post assessment
Conditions Studied
Interventions
- DEVICE Wearable Sensors
Study Locations (2)
Texas
- Ascension Health - Austin
- Texas A&M University - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2024-10-01 |
What the registry record for NCT06065319 still lists
NCT06065319 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 164-participant average among 13 other Cardiac Rehabilitation trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Cardiac Rehabilitation appearing as the primary indexed condition, and to 1 intervention - of which Wearable Sensors is the first listed.
NCT06065319 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06065319 about?
NCT06065319 is a clinical study titled "Wearables and Cardiac Rehabilitation". The goal of this study is to collect wearable sensor data that the investigators hypothesize will be useful in future algorithm development for monitoring recovering of participants enrolled in cardiac rehabilitation programs. Participants will be provided one or more smartwatches and/or smart rings...
What is the current status of trial NCT06065319?
This trial is currently active not recruiting. The enrollment target is 18 participants. The study started on 2023-10-01. Estimated completion is 2024-10-01.
What conditions does trial NCT06065319 study?
This clinical trial studies the following conditions: Cardiac Rehabilitation.
What interventions are being tested in trial NCT06065319?
The interventions under investigation include: Wearable Sensors (DEVICE).
Who is sponsoring clinical trial NCT06065319?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06065319 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Rehabilitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06065319's enrollment target sits among peer trials
18 14th of 13 the lowest of 13 other Cardiac Rehabilitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Rehabilitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
RECRUITING · NA
-
The Heart Health After Cardiac Treatment Study
RECRUITING · NA
-
SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation
RECRUITING · NA
-
Using a mHealth Intervention to Promote Physical Activity in Phase III Cardiac Rehabilitation Clients
RECRUITING · NA
-
Behavioral Exposure for Introceptive Tolerance RCT
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI